A role for AKT1 in nonsense-mediated mRNA decay

Archive ouverte

Palma, Martine | Leroy, Catherine | Salomé-Desnoulez, Sophie | Werkmeister, Elisabeth | Kong, Rebekah | Mongy, Marc | Le hir, Hervé | Lejeune, Fabrice

Edité par CCSD ; Oxford University Press -

International audience. Nonsense-mediated mRNA decay (NMD) is a highly regulated quality control mechanism through which mRNAs harboring a premature termination codon are degraded. It is also a regulatory pathway for some genes. This mechanism is subject to various levels of regulation, including phosphorylation. To date only one kinase, SMG1, has been described to participate in NMD, by targeting the central NMD factor UPF1. Here, screening of a kinase inhibitor library revealed as putative NMD inhibitors several molecules targeting the protein kinase AKT1. We present evidence demonstrating that AKT1, a central player in the PI3K/AKT/mTOR signaling pathway, plays an essential role in NMD, being recruited by the UPF3X protein to phosphorylate UPF1. As AKT1 is often overactivated in cancer cells and as this should result in increased NMD efficiency, the possibility that this increase might affect cancer processes and be targeted in cancer therapy is discussed.

Suggestions

Du même auteur

Use of 2,6-diaminopurine as a potent suppressor of UGA premature stop codons in cystic fibrosis

Archive ouverte | Leroy, Catherine | CCSD

International audience. Nonsense mutations are responsible for around 10% of cases of genetic diseases, including cystic fibrosis. 2,6-diaminopurine (DAP) has recently been shown to promote efficient readthrough of ...

Identifying Potent Nonsense-Mediated mRNA Decay Inhibitors with a Novel Screening System

Archive ouverte | Carrard, Julie | CCSD

International audience. Nonsense-mediated mRNA decay (NMD) is a quality control mechanism that degrades mRNAs carrying a premature termination codon. Its inhibition, alone or in combination with other approaches, co...

2,6-Diaminopurine as a highly potent corrector of UGA nonsense mutations

Archive ouverte | Trzaska, Carole | CCSD

International audience. Nonsense mutations cause about 10% of genetic disease cases, and no treatments are available. Nonsense mutations can be corrected by molecules with nonsense mutation readthrough activity. An ...

Chargement des enrichissements...